At close: December 13 at 9:52:06 PM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 17R.BE | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Maintains | Piper Sandler: Neutral to Neutral | 11/14/2024 |
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/1/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/1/2024 |
| Upgrade | Wells Fargo: Equal-Weight to Overweight | 10/21/2024 |
| Initiated | Scotiabank: Sector Outperform | 10/16/2024 |
| Maintains | Leerink Partners: Outperform to Outperform | 10/11/2024 |
Related Tickers
FHTX Foghorn Therapeutics Inc.
5.30
-8.30%
MEIP MEI Pharma, Inc.
2.7000
0.00%
APTO Aptose Biosciences Inc.
0.1930
+0.26%
ABVC ABVC BioPharma, Inc.
0.5050
-1.94%
SVRA Savara Inc.
3.2100
-4.18%
VTGN Vistagen Therapeutics, Inc.
2.4300
-2.02%
PRTA Prothena Corporation plc
12.79
-7.39%
SLNO Soleno Therapeutics, Inc.
46.71
+0.93%
PBYI Puma Biotechnology, Inc.
2.8800
-1.37%
TARS Tarsus Pharmaceuticals, Inc.
52.50
+2.78%